Back

NAV3 is a genetic determinant of myocardial recovery in dilated cardiomyopathy and attenuates cardiac fibrosis

28 August 2022 (16:55 - 17:05)
Organised by:
Congress Presentation Part of: Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling Cardiomyopathies ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Naveen Pereira

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Increased Tenascin-C expression contributes to cardiac dysfunction and fibrosis in Duchenne muscular dystrophy
Associate Professor A. Kiss (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Desmoglein 2 mutant mice reproduce arrhythmogenic right ventricular cardiomyopathy patients' phenotype
Doctor S. Ohno (Suita, JP)
Abstract Slides Video
Presentation thumbnail
The role of the atrium in the development of the Takotsubo Syndrome - investigation of a patient-specific atrial stem cell model
Doctor K. Streckfuss-Boemeke (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Dysferlin facilitates the de novo biogenesis of tubular membranes in hypertrophic remodelling
Ms N. Paulke (Goettingen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling

The Event

Event poster

ESC Congress 2022

28 August 2022 16:55 CET
You may be interested in
thumbnail
Congress Session
Cardiomyopathies/Channelopathies
thumbnail
Congress Presentation
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies for gene discovery
thumbnail
Congress Session
Novel mechanisms in arrhythmogenic cardiac diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources